透析肾衰竭患者家庭步行锻炼计划的遗留效应
EXCITE试验的事后研究评估透析患者6个月家庭步行锻炼结束后至36个月的效果维持情况。162例患者纳入分析,运动组6个月时步行距离获得组间差异+36米(95%CI 22-51,P<.001),18个月时维持+37米(95%CI 19-57,P<.001),36个月时降至23米(95%CI -4至49,P=.10)。结论认为步行获益可延续至干预结束后并延缓步行能力自然下降,但未影响生活质量和5次坐立试验反应。
要点
- 运动组6个月时步行距离组间差异+36米,18个月时维持+37米,36个月时降至23米未达统计学显著。
- 6个月和18个月步行距离变化与试验期间完成的规律运动次数直接相关(r=0.34,P=.018;r=0.30,P=.043)。
- 5次坐立试验反应和KDQOLSF-SF™测量的生活质量未见此类效应。
核心结论
- 透析患者6个月结构化步行锻炼计划的获益可延续至干预结束后,并延缓该人群步行能力的自然下降,但不影响生活质量和5次坐立试验反应。
研究设计与样本
- EXCITE试验的事后研究,嵌入EXCITE试验队列,检测从第6个月(试验结束)至第36个月对6分钟步行试验、5次坐立试验和KDQOLSF-SF™的反应。
- EXCITE试验队列227例患者中,162例完成方案规定的四次检测访视(基线、6、18和/或36个月)中至少三次,89例完成全部四次检测访视。
主要发现
- 线性混合模型主要分析中,运动组第6个月获得的步行距离组间差异为+36米(95%CI 22-51,P<.001),第18个月维持+37米(95%CI 19-57,P<.001),第36个月降至23米(95%CI -4至49米,P=.10)。
- 两研究组步行距离轨迹的试验后总体差异高度显著(P=.004)。
- 第6个月(r=0.34,P=.018)和第18个月(r=0.30,P=.043)的步行距离变化与试验期间(即前6个月)完成的规律运动次数直接相关。
- 5次坐立试验反应或KDQOLSF-SF™测量的生活质量未记录到此类效应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The EXerCise Introduction To Enhance performance (EXCITE) trial (J Am Soc Nephrol 28: 1259-1268, 2017) in dialysis patients showed that a 6-month home walking exercise programme improves physical function and two dimensions of the Kidney Disease Quality of Life Short Form (KDQOLSF-SF™) questionnaire. Whether improvements in physical function achieved by exercise interventions are maintained in the long term has never been tested in the dialysis population. METHODS: In this post-trial study embedded in the EXCITE trial, we tested the response to the 6 min walking test (6MWT) and the 5-time Sit-To-Stand (5STS) tests and the KDQOLSF-SF™ from the 6th month (end of the trial) to the 36th month. RESULTS: Among the 227 patients of the EXCITE trial cohort, 162 underwent at least three out of four testing visits (baseline, 6, 18 and/or 36 months) contemplated by the study protocol and 89 during all four testing visits. In the primary analysis by the linear mixed model, the gain in walking distance achieved in the 6th month in the exercise group [between-arms difference: +36 m, 95% confidence interval (CI): 22-51, P < .001] was maintained at the 18th month (between-arms difference: +37 m, 95% CI: 19-57, P < .001) and reduced to 23 m (95% CI: -4 to 49 meters, P = .10) at the 36th month. Overall, the post-trial difference in walking distance trajectories between the two study arms was highly significant (P = .004). Furthermore, the walking distance changes at the 6th (r = 0.34, P = .018) and 18th month (r = 0.30, P = .043) were directly related to the number of structured exercise sessions completed during the trial (i.e. the first 6 month). No such effect was registered in the response to the 5STS or in quality of life as measured by the KDQOLSF-SF™. CONCLUSIONS: In dialysis patients, the benefits of a 6-month structured walking programme outlast the duration of the intervention and postpone the loss of walking performance which naturally occurs in this population, but does not affect the quality of life (QoL) and the response to the STS test.
引用
- Manfredini F, D'arrigo G, Lamberti N, et al. The legacy effect of a home walking exercise programme in kidney failure patients on dialysis. Nephrol Dial Transplant. 2022. PMID: 35641182. doi:10.1093/ndt/gfac147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。